摘要
目的:比较微创穿刺血肿抽吸术联合尿激酶治疗与小骨窗开颅血肿清除术治疗高血压脑出血的疗效优劣。方法:入选病人根据随机原则分成两组,并取得患者或其家属同意,一组使用YL-1进行微创穿刺治疗高血压脑出血,术后联合使用尿激酶2万单位,每日一次血肿腔内给药,并持续引流;另一组采用小骨窗开颅血肿清除术,直接清除血肿。结果:两组患者在NIHSS评分和3个月预后GOS评分上的差异无统计学意义,但微创穿刺具有创伤小、治疗效果与开颅组相同、住院时间短、并发症少等优点。结论:在预后无明显差异情况下,选择住院时间短,创伤小,易于开展的治疗方法。对于血肿量在30-60m1的基底节区脑出血患者,选择微创穿刺血肿抽吸术,优于小骨窗开颅治疗。对于血肿量较大,有生命体征紊乱的患者,如果医院具备开颅手术条件,进行开颅手术,可以尽快解除颅高压,有效控制病情发展速度。
Objective:To compare the curative effect of minimally invasive treatment of hematoma aspiration combined urokinase therapy and the small bone window hematoma evacuation for hypertensive cerebral hemorrhage merits.Methods:The selected patients which were permitted by their families were randomly divided into two groups based on the screening principles. One group using the YL-1 hematoma puncture needle for minimally invasive treatment of hypertensive cerebral hemorrhage, after the operation administrated 2 ten- thousand units urokinase into hematoma cavity daily. the other taking hematoma evacuation with a small bone window in order to remove the hematoma. Results:There was no significant difference in the NIHSS score and 3-month outcome on the GOS score, but minimally invasive with less trauma, shorter hospital stay, fewer complications and the same treatment effect compared with the craniotomy group. Conclusion:If there is no significant difference in the final prognosis of the case, try to select the shorter length of stay, less invasive, easy to carry out the treatment. Selecting the minimally invasive treatment in the supratentorial intracerebral hematoma of 30 60ml volume patients, is better than the treatment of small bone window craniotomy. To the larger amount of hematoma volume with life disorders patients, craniotomy can be lifted intracranial hypertension as soon as possible and controlled the rate of progression of the disease effectively if the hospital conditions were permitted.
引文
[1]Douglas MA, Haerer AF. Long-term prognosis of hypertensive intracerebral hemorrhage[J]. Stroke.1982,13(4):488-491.
[2]Helweg-Larsen S, Sommer W, Strange P, et al. Prognosis for patients treated conservatively for spontaneous intracerebral hematomas[J]. Stoke.1984,15(6):1045-1048.
[3]Counsell C, Boonyakarnkul S, Dennis M, et al. Primary intracerebral haemorrhage in the Oxfordshire Community Stroke Project[J].Cerebrovasc Dis.1995,5(2):26-34.
[4]Payne, Krista A, Huybrechts, et al. Long Term Cost-of-Illness in Stroke:An international Review[J]. Pharmacoeconomics.2002,20(12):813-825.
[5]王德江,赵继宗,王梅.高血压脑出血外科治疗的成本-效果比较研究[J].中国医药导刊,2006,8(2):127-130.
[6]马英文,李辉,刘捷等.高血压脑出血血肿吸收吸收时间影响因素探察[J],中华神经医学杂志,2005,4(1):54-56.
[7]邱继忠,范春明,韦凤媛.高血压脑出血微创治疗现状(J].中国综合临床,2003,19(5):391-392.
[8]王建清,陈衔城,吴劲松等.高血压脑出血手术时机的规范化研究[J].中国微侵袭神经外科杂志,2003,8(1):21-24.
[9]吕宪民,冯凯,曹亦宾等.不同方法治疗高血压脑出血81例[J].中国煤炭工业医学杂志,2004,7(3):263-264.
[10]张建军,董伟峰,张俊等.高血压脑出血急诊分类归属对预后影响的研究[J].浙江创伤外科,2004,9(1):18-20.
[11]何升雷.微创开颅经脑沟手术治疗高血压脑出血疗效观察[J].中国误诊学杂志,2005,5(2):263-264.
[12]李毓生,赵艳,杨成宝.高血压脑出血手术时机与适应证的探讨[J].内蒙古民族大学学报(自然科学版),2004,19(2):225-227.
[13]周良辅,庞力.高血压脑出血的微侵袭手术治疗-前瞻随机多中心研究(J).中国临床神经科学,2001,9(2):151-154.
[14]尹晓亮.高血压脑出血外科治疗的进展[J].北京医学,2006,28(3):175-177.
[15]Hankey GJ,Hon C.Surgery for primary intracerebral hemorrhage:is it safe and effective? A systematic review of case series and randomized trials.Stroke,1997,28: 2126-2132.
[16]Fernandes HM, Greson B, Siddique S, et al. Surgery for primary supratentorial intracerebra hemorrhage:the uncertainty continues. Stroke,2000,31:2511-2516.
[17]黄光树,蒋万书.高血压脑出血外科治疗[J].实用医院临床杂志,2004,1(1):15-17.
[18]王忠诚主编.神经外科学[M].武汉:湖北科学技术出版社,2001,第2版,686-689.
[19]马颖,程远.YL-1型针穿刺碎吸术治疗高血压脑出血死亡原因分析[J].重庆医科大学学报,2004,29(4):526-528.
[20]廖光查,覃刚,吴海春等.高龄高血压脑出血的超早期手术治疗效果观察[J].广西医学,2004,26(2):183-184.
[21]陈润成,王合金,谭朝晖.微创清除术救治重症高血压脑出血的临床观察[J].临床神经病学杂志,2004,17(3):216-217.
[22]吴振宏.多针穿刺治疗60m1以上高血压脑出血30例报道[J].中风与神经疾病杂志,2004,21(3):264.
[23]关俊文,刘茂健,吴华超等.颅内血肿微创清除术治疗高血压脑出血104例的随机对照研究[J].广东医学院学报,2004,22(2):133-135.
[24]厉永伟,贺侠,李锋等.脑出血微创颅内血肿清除治疗的研究[J].浙江临床医学,2004,6(3):163-164.
[25]高添喜,黄波,伍爱平等.微创术治疗高血压脑出血及其对神经功能早期康复的影响[J].中国康复医学杂志,2004,19(5):352-354.
[26]吴立国,杨玉霞,高改云.微创颅内血肿清除术治疗中重度高血压脑出血63例报告[J].中风与神经疾病杂志,2004,21(3):261-262.
[27]龚涛,易俊.微创清除与保守治疗高血压脑出血的效果比较[J].中国全科医学,2004,7(17):1255-1256.
[28]胡新明,陈永健,张学军.颅内血肿的微创手术治疗[J].立体定向和功能性神经外科杂志,2002,15(4c):223-224.
[29]常建波,黄雪松.高血压脑出血立体定向术后再出血原因分析[J].立体定向和功能性神经外科杂志,2002,13(1):49.
[30]Hemphillm JC, Bonovich DC, Besmertis L, et al. A simple, celled grading scale for intracerebral hemorrhage[J].Stroke,2000,32:891-897.
[31]Kaya RA, Turkmenoglu O, Ziyal IM, Dalkilic T, et al. The effects on prognosis of surgical treatment of hypertensive putaminal hematomas through transsylvia transinsular approach[J].Surgical Neurology,2003,59:176-183.
[32]李树春,赵振华.微创手术治疗高血压脑出血临床分析[J].中国现代神经疾病杂志,2005,5:171.
[33]李金彩,李中秋,陆兵勋等.脑立体定向微创手术治疗高血压脑出血[J].中华神经医学杂志,2006,5:855-856.
[34]赵继宗,倪明.微创手术治疗脑深部病变[J].中华神经外科疾病研究杂志,2002,1(4):293-295.
[35]王建清,陈衔城,吴劲松等.高血压脑出血手术时机的规范化研究[J].中国临床神经外科杂志,2003,8(1):21-24.
[36]中华神经科学会,中华神经外科学会,脑血管疾病分类及诊断[J].中华神经外科杂志,1997,13(1):34.
[37]冯家龙.高血压脑出血手术治疗方法探讨[J].重庆医学,2004,33(6):893-894.
[38]赵勇刚.高血压脑出血微创清除手术时机研究[J].中国综合临床,2003,19(9):816-817.
[39]赵新军,杜勇健,魏琳等.多因素量化预测高血压脑出血预后[J].神经疾病与精神卫生,2003,3(2):117-118.
[40]王春建,侯松玉,洪景芳,刘光,袁绍纪,张荣伟.显微锁孔开颅术治疗高血压脑出血[J].中华神经外科疾病研究杂志,2004,3(2):169-170.
[41]蒋尊柏,雷厉,胡丹.早期微创手术治疗高血压脑出血[J].中国内科杂志,2004,6(2):254.
[42]林欣,杨玉山,只达石.显微手术治疗高血压脑出血102例[J].天津医药杂志,2004,32(8):500.
[43]林晓东,赵丽,王学敏等.高血压脑出血微创术治疗的临床研究[J].中华神经医学杂志,2005,4(2):174-176.
[44]杨晓阳,黄黛,黄英.脑出血微创术后死亡原因分析[J].中国误诊学杂志,2003,3(11):1701-1702.
[45]Fadrus P, Smrcka V, Svoboda T. Stereoraxic evacuation of spontaneous intracerebral hemorrhage with monitoring of intracerebral pressure[J]. Bratisl Lek Listy.2004, 105(5-6):325.
[46]杨瑞霞.微创技术治疗高血压脑出血患者出现继续出血的因素分析[J].临床荟萃,2004,19(7):395-396.
[47]安贵群,许树元,刘宏亮.超早期微创开颅治疗高血压脑出血[J].实用临床医药杂志,2004,8(1):35-37.
[48]梁启龙,魏世旺,刘凯等.颅内血肿微创碎吸清除术临床分析.中华神经医学杂志,2005,4(2):178-180.
[49]陈子卿,庄耀明,黄培昆.微创清除术治疗高血压脑出血71例疗效观察[J].中国危重病急救医学,2004,16(4):252.
[50]刘锋利.高血压脑出血的微创手术治疗[J].实用医学杂志,2005,21(6):595-596.
[51]石金河,杨蕾,梁东良.微创穿刺术加尿激酶治疗超早期高血压脑出血[J].医师进 修杂志(内科版),2004,27(4):46-47.
[52]闰建萍,黄树华,林东等.微创颅内血肿清除术治疗重症高血压脑出血临床分析[J].适用神经疾病杂志,2005,8(2):43.
[53]林忠,李英斌,张健.急诊微创手术治疗高血压脑出血[J].临床医学,2004,24(8):8-9.
[54]李亚平,贺祯令,王全等.颅内血肿微创清除技术与小骨窗开颅手术治疗高血压脑出血临床对照分析[J].重庆医学,2004,33(10):1455-1457.
[55]韦俊德,韦俊田.高血压脑出血手术预后的影响因素[J].广西医科大学学报,2003,20(2):260-261.
[56]潘荣南,罗云平,吴雪松等.显微手术为主治疗高血压脑出血134例[J].广西医科大学学报,2004,21(2):265-266.
[57]黄波,陈冬妹,高添喜等.微创术治疗高血压脑出血36例临床分析[J].中国临床神经外科杂志,2004,9(1):70-71.
[58]章翔.脑卒中诊断治疗学[M].北京:人民军医出版社,2002,第1版,128-134.
[59]侯为民,刘文强.微创颅内血肿清除技术治疗高血压脑出血临床应用[J],医师进修杂志(外科版),2004,27(1):37-38.
[60]田万管,黎檀石,苏忠等.微创术治疗幕上高血压脑出血近期预后因素分析[J]第三军医大学学报,2003,25(17):1576-1578.
[61]周良铺主编.现代神经外科学[M].上海:复旦大学出版社,2001,第2版,801.
[62]高广伟,岳新灿,张剑宁.大骨瓣减压救治重型高血压脑出血的体会[J].中华神经外科疾病研究杂志,2004,3(3):273.
[63]宋洋,崔益钿,万青等.高血压脑出血的外科治疗[J].中华神经外科疾病研究杂志,2004,3(4):325-327.
[64]雷利华,周根来,兰威等.YL-1型微创穿刺术治疗高血压脑出血22例[J].浙江临床医学,2008,10(1):48.
[65]王宝华,于国平.不同微创手术治疗重症高血压脑出血的疗效比较[J].中国全科医学,2008,11(2A):251-252.
[66]周学金,刘子华.颅内出血的手术治疗时机与方式的选择探讨[J].中国现代药物应用2009,3(12):35-36.
[67]时晓光,师镜峰,李超等.高血压脑出血微创外科治疗588例总结[J].中华神经外科疾病研究杂志,2008,7(1):77-78.
[68]吴高远,高金华,钱洪波.微创术和小骨窗开颅术治疗高血压脑出血的疗效观察(附34例临床分析)[J].安徽医药,2006,10(2):124-126.
[69]招康东,招建华,关俊文等.尿激酶联合YL-1型血肿穿刺针微创治疗高血压脑出血的临床观察[J].实用医学杂志,2007,23(13):2073-2074.
[70]赵庆伟,张立杰,孙守成.超早期小骨窗开颅治疗重型高血压脑出血32例分析[J].现代医药卫生,2008,24(9):1355.
[71]尹先印,陶胜忠,牛光明等.小骨窗选择性治疗高血压脑出血的探讨[J].中国实用神经疾病杂志,2009,12(16):27-28.
[72]刘进,叶碎林,王伟明等.超早期微创治疗高血压脑出血临床对照研究[J].浙江创伤外科,2009,14(4):319-320.
[1]Sturgeon JD, Folsom AR. Trends in hospitalization rate, hospital case fatality, and mortality rate of stroke by subtype in Minneapolis[J]. Neuroepidemiology,2007, 28(1):39-45.
[2]王维治,罗祖明.神经病学[M].第4版.北京:人民卫生出版社,2001,9:142-148.
[3]张彬.高血压脑出血的外科治疗时展[J].医学综述,2007,1(4):288-299.
[4]Kingman TA, Mendelow AD, Graham DE, et al. Experinental intracerebral hemorr hage mass description of model, intracranial pressure changes and neuropathology [J].Neurothol Exp Neurol,1998,47(2):118-137.
[5]Lee KR, Kawai N, Kim S, et al. Mechanisms of edema formation after intracerebral hemorrhage:effects of thrombin on CBF BBB. Permeability and cell survival in a rat model [J].Neurosurg,2002,86:272-278.
[6]Quershi, Al, et al. Apoptosis as a from of cell death in intracerebral hemohrrage. Neurosurgeyr[J].2003,52(5):1041-1048.
[7]Bennett SAL, Tenniswood M, Chen JH, et al. Chronic cerebral hypoperfusion elicits neuronal apoptosis and behavioral impairment[J]. Neuroreport,1998,9:161.
[8]Masada T, Xi G, Hua Y, et al. The effects of thrombin preconditioning on focal cerebral ischemia in rats[J]. Brain Res,2000,867(12):173-179.
[9]Muprhy AN, Fiskum G, Beal MF. Mitochondria in neurodegeneration:bioenergetic function in cell life and death[J]. Cereb Blood Flow Metab,1999,19(7):231-240.
[10]Xue M, Del Bigio MR.Intracortical hemorrhage injury in rats:relationship between blood fractions and brain cell death[J]. Stroke,2000,31 (7):1721-1727.
[11]Misra UK, Kalita J, Ranjan P, et al. Mannitol in intracerebral hemorrhage:a randomized controlled study[J].Neurol Sci.2005,15 (12):41-45.
[12]徐林新,李新立,吴秀芳,等.不同剂量甘露醇对高血压性脑出血血肿及脑血流动力学的影响[J].实用医药杂志.2002,10(19):765-767.
[13]Peck P. News from the ASA stroke conference:new treatment for cerebral hemorrhage: haemostatic factor VII. Neurology today,2003,3(2):22.
[14]王忠诚,王忠诚.神经外科学[M].武汉:湖北科学技术出版社,2006:866-867.
[15]Hemphillm JC, Bonovich DC, Besmertis L, et al. A simple, celled grading scale for intracerebral hemorrhage[J].Stroke,2000,32:891-897.
[16]Kaya RA, Turkmenoglu O, Ziyal IM, Dalkilic T, et al. The effects on prognosis of surgical treatment of hypertensive putaminal hematomas through transsylvia transinsular approach[J].Surgical Neurology,2003,59:176-183.
[17]李树春,赵振华.微创手术治疗高血压脑出血临床分析[J].中国现代神经疾病杂志,2005,5:171.
[18]李金彩,李中秋,陆兵勋,等.脑立体定向微创手术治疗高血压脑出血[J].中华神经医学杂志,2006,5:855-856.
[19]王建清,陈衔城,吴劲松,等.高血压脑出血手术时机的规范化研究[J].中国临床神经外科杂志,2003,8(1):21-24.
[20]丁宏岩,董强.自由基清除剂依达拉奉对脑出血的治疗作用[J].国外医学脑血管疾病分册,2004,12:491-493.
[21]李伟.依达拉奉对高血压脑出血手术患者的治疗作用[J].中国实用医药.2008,6(3)28-29.
[22]缪海燕,陈立新,缪月华.高血压脑出血术后高压氧治疗临床分析[J].现代中西医结合杂志.2008,17(7):106